Traynor Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Traynor Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$41K	–	223
2022 Q1	$41K	Sell	10,000 -1,000	-9%	-$3.63K	0.01%	194
2021 Q4	$39K	Sell	11,000 -1,000	-8%	-$3.5K	﹤0.01%	214
2021 Q3	$43K	Buy	+12,000	New	+$48.5K	0.01%	191

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Traynor Capital Management's ATRS Position: Q2 2022 in Review

Traynor Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Traynor Capital Management first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $43K in Q3 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Traynor Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Traynor Capital Management sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
Traynor Capital Management first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Traynor Capital Management's Antares Pharma, Inc. position peaked at $43K in Q3 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Traynor Capital Management's 13F filing for Q2 2022, filed 28 Jul 2022.